Published: Sunday, December 29, 2024 · 11:30 PM | Updated: Sunday, December 29, 2024 · 11:30 PM
📊 535 views
Siemens CFO Ralf Thomas announced that the company is assessing its majority stake in its medical technology subsidiary, Siemens Healthineers. Thomas mentioned that the synergy between Siemens and the MRI and lab systems manufacturer does not justify the €45 billion ($46.91 billion) capital commitment, referring to Siemens’ 75% stake in Healthineers.
He stated that Siemens is evaluating economic opportunities in healthcare to determine the investment’s role, with conclusions expected by the end of 2025 during Siemens’ Capital Markets Day. Siemens spun off Healthineers in 2018, maintaining a majority stake. However, Thomas recently indicated that Siemens might sell about 5% of Healthineers to fund the acquisition of U.S. software company Altair.
Thomas also reaffirmed Siemens’ commitment to its Mobility train division, despite investor calls for divestiture, emphasizing the business’s strategic value to Siemens.
MORE IN INSIDE INVESTMENT NEWS
AI Funding Fears Rattle Wall Street: Adjusting for Alpha and Preservation
Published: Saturday, October 24, 2026 · 12:28 PM
Volvo Cars Plunge: Alpha Warning as China Sales Slump Hits Earnings
Published: Friday, October 23, 2026 · 6:18 AM
